TL;DR: A 2026 study in Scientific Reports identified a novel OPHN1 K306N variant in a boy with cyclic strabismus, linking a 24-hour eye-alignment rhythm to altered phosphoinositide binding without the intellectual disability usually associated with OPHN1 syndrome. Key Findings 8-year-old patient: A Japanese boy had cyclic esotropia, with left eye crossing in the morning and …
TL;DR: A 2026 study in Implementation Science Communications found that high-performing HEALing Communities Study coalitions used representative membership, shared goals, data support, and communications campaigns to strengthen opioid-use-disorder service implementation. Key Findings 8 communities studied: Researchers selected the top-performing urban and rural waitlist-control communities from each of four HEALing Communities Study sites. 41 interviews analyzed: …
TL;DR: A 2026 Journal of Global Health analysis of Global Burden of Disease 2021 data estimated that 162.86 million people had substance use disorders in 2021, with age-standardized rates down since 1990 but major inequality across sex, age, region, and development level. Key Findings 162.86 million cases: Global Burden of Disease 2021 estimates put worldwide …
TL;DR: A 2026 Nature Communications study used long-read single-cell RNA sequencing to map full-length isoforms in glioblastoma and found tumor-specific transcripts that short-read methods often miss. Key Findings 27 GBM samples: Researchers profiled histologically confirmed IDH-wildtype glioblastoma samples using matched short-read and long-read single-cell sequencing. 100 million reads: The optimized long-read workflow produced a median …
TL;DR: A 2026 systematic review and meta-analysis in International Journal of Obesity found that glucagon-like peptide-1 receptor agonists, metabolic drugs that extend a satiety and glucose-control hormone pathway, reduced body weight mainly through fat loss while lean-mass reductions were generally modest. Key Findings 36 studies reviewed: Researchers included 36 studies in the qualitative review and …
TL;DR: A 2026 randomized pilot study in JMIR Formative Research found that one brief yoga session did not significantly change salivary cortisol compared with quiet sitting, but it did raise heart rate during the active movement phase. Key Findings Yoga pilot sample: The pilot randomized 19 adults, with 10 participants assigned to a 24-minute yoga …
TL;DR: A 2026 study in Open Life Sciences reported that ELAVL1, an RNA-binding protein, protected stressed retinal cells by maintaining WDR36 protein, reducing p53 activation, and limiting calcium overload in cell and acute mouse pressure-injury models. Key Findings OGD/R cell stress: Oxygen-glucose deprivation/reoxygenation reduced ELAVL1 and WDR36 protein in R28 retinal precursor cells. mRNA-protein mismatch: …
TL;DR: A 2026 mouse study in Nature Communications found that early-life high-fat/high-sugar diet exposure left sex-specific adult feeding and hypothalamic changes, and microbiota-targeted interventions partly restored those effects. Key Findings Early-life HFHS exposure: Mice exposed to a high-fat/high-sugar diet only in early life showed persistent adult feeding changes despite normalized body weight. Sex-specific vulnerability: Females …
TL;DR: A 2026 systematic review and meta-analysis in International Journal of Molecular Sciences found no significant global gut-microbiome alpha-diversity difference in schizophrenia, but reported recurring community-composition and taxonomic shifts. Key Findings 48 studies: The review included 48 human observational studies published between 2017 and 2025. 14 meta-analyzed studies: Only 14 studies provided enough data for …
TL;DR: A 2026 narrative review in Neurological Research and Practice argued that Parkinson’s prevention is most actionable through physical activity, Mediterranean-style diet patterns, toxin reduction, earlier prodromal detection, and better rehabilitation after diagnosis. Key Findings Fastest-growing neurological disorder: The review described Parkinson’s disease as the fastest-growing neurological disorder worldwide. 6.2 to 11.8 million cases: A …
